Zdrowie i gospodarka · 30/11/1998
FDA Releases Draft Guidance on Pediatric Pharmacokinetic Studies for Drugs and Biological Products
The Food and Drug Administration (FDA) has made available a draft guidance document to help pharmaceutical companies prepare pediatric pharmacokinetic studies, enabling the labeling of drugs and biological products for use in children.
Source: Federal Register — Food and Drug AdministrationOpen original release →